BioVision Plus
Cabinet, X-Ray System. 510(k) K153583, from Faxitron Bioptics, LLC (Tucson, AZ). Product code MWP, class 2.
As of Nov 20, 2026, K153583 is an FDA 510(k) held by Faxitron Bioptics, LLC, substantially equivalent on Apr 1, 2016 after 108 days, with no recalls tied to it in FDA's recall database.
- Review time: 108 days
- Recalls: 0
- Cited as a predicate by: 2 devices
The BioVision (Plus/+)Digital Specimen Radiography (DSR) System is a cabinet digital X-ray imaging system intended to generate and control X-rays for examination of harvested specimens from various anatomical regions, and to provide rapid verification that the correct tissue has been excised.
- Biovision Digital Specimen Radiography SystemK091558 · Bioptics, Inc. · Jul 17, 2009
- Faxitron VisionCTK173309 · Faxitron Bioptics, LLC · May 9, 2018
- Faxitron Bioptics Speciemen Radiography SystemK170786 · Faxitron Bioptics, LLC · Jul 18, 2017
- TrueView 200 Pro-US Specimen Radiography System (TrueView 200 Pro-US)K230136 · Compai Healthcare (Suzhou) Co.,Ltd · Apr 24, 2023
- TrueView Core 100Pro-US Core Specimen Radiography System (TrueView Core 100Pro-US)K230140 · Compai Healthcare (Suzhou) Co.,Ltd · Apr 24, 2023
- Solas ORK213691 · Cirdan Imaging, Ltd. · Dec 22, 2021
- Kubtec Mozart Supra (XPERT 84) Radiography SystemK210955 · Kub Technologies, Inc. · Sep 20, 2021
- Kubtec Mozart (XPERT42)K210956 · Kub Technologies, Inc. · Aug 31, 2021
- Kubec Xpert 80 Radiography SystemK210957 · Kub Technologies, Inc. · Aug 31, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Dec 15, 2015
- Review panel
- Radiology
- Regulation
- 21 CFR 892.1680
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files